供应WHO92/654可溯源人血浆中纤溶酶原激活物抑制剂-1国际标准物质PAI-1

供应WHO92/654可溯源人血浆中纤溶酶原激活物抑制剂-1国际标准物质PAI-1

产品详情如下,更多产品价格和货期,请咨询客服!

The Standard consists of reactivated recombinant (in Chinese hamster ovary cells) PAI-1 (1) added to normal human plasma and lyophilized following ampouling at NIBSC.

The preparation contains material of human origin, and either the final product or the source materials, from which it is derived, have been tested and found negative for HBsAg, anti-HIV and HCV RNA. As with all materials of biological origin, this preparation should be regarded as potentially hazardous to health. It should be used and discarded according to your own laboratory’s safety procedures. Such safety procedures should include the wearing of protective gloves and avoiding the generation of aerosols. Care should be exercised in opening ampoules or vials, to avoid cuts.

本标准由重新激活的重组(在中国仓鼠卵巢细胞中)PAI-1(1)添加到正常人血浆中,并在NIBSC上安瓿后冻干。

该制剂含有人类来源的材料,其最终产物或来源材料经过测试,发现HBsAg、抗HIV和HCV RNA呈阴性。与所有生物来源的材料一样,这种制剂应被视为对健康有潜在危害。应根据您自己实验室的安全程序使用和丢弃它。此类安全程序应包括佩戴防护手套和避免产生气溶胶。打开安瓿或小瓶时应小心,以避免割伤。

Product Number 92/654 WHO92/654
Product Description Plasminogen Activator Inhibitor-1 (PAI-1), plasma Human WHO International Standard 可溯源人血浆中纤溶酶原激活物抑制剂-1国际标准物质PAI-1
Type of Standard International Standard
Category Biotherapeutics > HaemostasisBiotherapeutics
Instructions for Use 92-654.pdf
Keywords Serpin, tPA, Urokinase
Related Products 87/594, 94/730, 98/714,
Customer Notes Activity standard of recombinant PAI-1 in plasma
Minimum Quantity 1